Director/PDMR Shareholding

RNS Number : 7936E

IP Group PLC

31 October 2022

 

FOR RELEASE ON

31 October 2022

IP Group plc - PDMR share purchase

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, has been notified that on 28 October 2022, Christopher Glasson, Finance Director and a PDMR, purchased a total of 74,615 ordinary shares of two pence each ("Shares") as outlined in the below table.

Name	Number of Shares acquired	Price per share (£)	Resultant beneficial interest (in Shares)
Christopher Glasson	74,615	£0.59	137,749

The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Christopher Glasson
2	Reason for the notification
a)	Position/status	Finance Director (PDMR)
b)	Initial notification/Amendment	Initial Announcement
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IP Group plc
b)	LEI	213800HG22UM138WFG43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 2p each in IP Group plc ISIN: GB00B128J450
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s)  59 pence per share 74,615
d)	Aggregated information -  Aggregated volume -  Price	Not applicable - single transaction
e)	Date of the transaction	28 October 2022
f)	Place of the transaction	London Stock Exchange, Main Market

For more information, please contact:

IP Group plc	www.ipgroupplc.com
David Baynes, Chief Financial and Operating Officer Liz Vaughan-Adams, Communications	[phone] [phone]/[phone]

Notes for editors

About IP Group

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com .

ENDS

 

END

 

 

DSHWPGCWUUPPGQG